Investment Approach

Symphony invests in the clinical development programs of biopharmaceutical companies, enabling them to increase funding and accelerate the development of their product pipelines.

We form Symphony Collaborations with leading innovative biopharmaceutical companies that have significant internally developed clinical programs or attractive in-licensed or acquired products. Each Symphony Collaboration is a distinct portfolio company in which the capitalization, clinical development design and management resources are tailored to accelerate the development of 2-4 pipeline candidates of a single biopharmaceutical company.

 
Copyright 2002- © Symphony Capital LLC. All rights reserved.